Developments, news and strategies for drug development specific to phase I through Phase III global clinical trial management, execution, project management and outsourcing. Go→
News, articles and issues specific to clinical trial practice and implementation at the investigative site level. Go→
Strategies and innovations related to how clinical professionals are utilizing technology internal and external to their organizations to advance clinical trials. Go→
News, articles and issues specific to laboratories role in the clinical trial, including ECG, imaging, genotyping, tissue samples and more. Go→
News, developments and strategies for clinical trials conduct in relation to the FDA, EMEA and other global regulatory authorities overseeing the drug development industry. Go→
News, articles and strategies related to clinical trial design which impact postmarketing studies, therapeutic areas, adaptive trials, statistics, protocols and more. Go→
On March 13, the European Medicines Agency (EMA) published updated information about current tenders—documents that explain a project and its requirements to intending bidders—worth more than £60,000 ($99,700).
The newest tender to be unveiled consists of a contract worth 1.2 million euros for the provision of information resources at the Agency itself. The closing date is June 4, 2014.
Further details about the latest tenders—which typically contain a notice inviting tenders, instructions to bidders, the conditions, form of submission, and bill of quantities—are available via this link: